SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Return
62.95%
This Quarter Return
+0.56%
1 Year Return
-62.95%
3 Year Return
-60.35%
5 Year Return
-56.94%
10 Year Return
–
AUM
$282M
AUM Growth
+$47.3M
(+20%)
Cap. Flow
+$44.5M
Cap. Flow
% of AUM
15.78%
Top 10 Holdings %
Top 10 Hldgs %
41.57%
Holding
793
New
124
Increased
53
Reduced
53
Closed
142
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$40M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$10.3M |
| 3 |
Bausch Health
BHC
|
$7.27M |
| 4 |
Albemarle
ALB
|
$6.79M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$6.66M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$24.4M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$10M |
| 3 |
Amgen
AMGN
|
$7.8M |
| 4 |
Pinduoduo
PDD
|
$6.55M |
| 5 |
Cracker Barrel
CBRL
|
$5.94M |
Sector Composition
| 1 | Healthcare | 38.32% |
| 2 | Communication Services | 18.14% |
| 3 | Technology | 10.64% |
| 4 | Consumer Discretionary | 8.64% |
| 5 | Financials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Spotify
SPOT
$146B
| $113K | ﹤0.01% |
500
| – | – |
|
202
CRISPR Therapeutics
CRSP
$4.99B
| $112K | ﹤0.01% |
+1,000
| New | +$112K |
|
|
CERN
203
DELISTED
Cerner Corp
CERN
| $106K | ﹤0.01% |
+1,500
| New | +$106K |
|
|
XLNX
204
DELISTED
Xilinx Inc
XLNX
| $106K | ﹤0.01% |
+700
| New | +$106K |
|
205
Atea Pharmaceuticals
AVIR
$267M
| $105K | ﹤0.01% |
+3,000
| New | +$105K |
|
206
Golar LNG
GLNG
$4.52B
| $104K | ﹤0.01% |
8,000
| – | – |
|
207
PNC Financial Services
PNC
$80.5B
| $98K | ﹤0.01% |
500
-1,000
| -67% | -$196K |
|
208
DraftKings
DKNG
$23.1B
| $96K | ﹤0.01% |
2,000
-16,000
| -89% | -$768K |
|
209
IQVIA
IQV
$31.9B
| $96K | ﹤0.01% |
400
-1,100
| -73% | -$264K |
|
|
QTNT
210
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $94K | ﹤0.01% |
+1,000
| New | +$94K |
|
211
C3.ai
AI
$2.15B
| $93K | ﹤0.01% |
2,000
-4,000
| -67% | -$186K |
|
212
Genius Sports
GENI
$3.22B
| $93K | ﹤0.01% |
+5,000
| New | +$93K |
|
|
CS
213
DELISTED
Credit Suisse Group
CS
| $92K | ﹤0.01% |
9,300
| – | – |
|
214
Sangamo Therapeutics
SGMO
$165M
| $90K | ﹤0.01% |
10,000
+7,500
| +300% | +$67.5K |
|
215
Cameco
CCJ
$33B
| $87K | ﹤0.01% |
4,000
-28,500
| -88% | -$620K |
|
|
RMO
216
DELISTED
Romeo Power, Inc.
RMO
| $86K | ﹤0.01% |
17,400
+4,900
| +39% | +$24.2K |
|
|
SQSP
217
DELISTED
Squarespace, Inc.
SQSP
| $81K | ﹤0.01% |
+2,084
| New | +$81K |
|
218
Ascendis Pharma
ASND
$12.5B
| $80K | ﹤0.01% |
500
-3,500
| -88% | -$560K |
|
219
BeyondSpring
BYSI
$75M
| $79K | ﹤0.01% |
+5,000
| New | +$79K |
|
220
Peabody Energy
BTU
$2.33B
| $74K | ﹤0.01% |
+5,000
| New | +$74K |
|
221
Hologic
HOLX
$14.8B
| $74K | ﹤0.01% |
+1,000
| New | +$74K |
|
222
Digital Realty Trust
DLR
$55.7B
| $72K | ﹤0.01% |
+500
| New | +$72K |
|
223
Rekor Systems
REKR
$138M
| $69K | ﹤0.01% |
6,000
-146,000
| -96% | -$1.68M |
|
|
VIEW
224
DELISTED
View, Inc. Class A Common Stock
VIEW
| $65K | ﹤0.01% |
+200
| New | +$65K |
|
225
iHeartMedia
IHRT
$315M
| $63K | ﹤0.01% |
+2,500
| New | +$63K |
|